Showing results (371-380 of 416) with videos related to
Sort By:
Pageof 42
Antioxidants (Basel, Switzerland)|September 28, 2021
Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer CellsAntonio J León-González, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
A Phase II Randomized Study of Paclitaxel alone or combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor Positive Breast Cancer: the BRACELET-01/PrE0113 studyAmy S Clark, Fengmin Zhao, Paula Klein, et al.Journal of Clinical Medicine|June 6, 2020
Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate CancerPrudencio Sáez-Martínez, Juan M Jiménez-Vacas, Antonio J León-González, et al.Cancer Letters|January 20, 2024
Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1Prudencio Sáez-Martínez, Francisco Porcel-Pastrana, Antonio J Montero-Hidalgo, et al.Revista Espanola De Medicina Nuclear E Imagen Molecular|May 21, 2022
Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological nodeJ Fuertes Manuel, S Kohan, M Jordà Solé, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast CancerNickolas Stabellini, Mantas Dmukauskas, Marcio S Bittencourt, et al.Breast Cancer Research and Treatment|December 6, 2011
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancerA J Montero, C M Diaz-Montero, Y E Deutsch, et al.NPJ Breast Cancer|June 25, 2026
Prognostic consistency of oncotype DX® molecular assay across racial groups in early-stage hormone receptor-positive breast cancerReine Abou Zeidane, Benjamin Hauk, Samuel Lichtman-Mikol, et al.JAMA Oncology|November 5, 2020
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical TrialVeronica Mariotti, Hyo Han, Roohi Ismail-Khan, et al.European Journal of Ophthalmology|August 2, 2024
A randomised study comparing performance and safety of Eyestil Plus® vs Vismed Multi® in moderate-to-severe dry eye syndrome patientsP J Pisella, P Gain, B Cochener, et al.Pageof 42